ViennaLab Diagnostics is a molecular diagnostics company headquartered in Vienna, Austria, dedicated to the development of convenient and reliable in vitro diagnostic (IVD) solutions for the detection of genetic variations associated with hereditary diseases, genetic susceptibility, pharmacogenomics, cancer, and the human microbiome.The company provides comprehensive diagnostic technologies ranging from rapid single-marker assays to complex genetic analysis solutions, enabling laboratories to perform accurate and efficient molecular testing.ViennaLab Diagnostics integrates advanced molecular technologies to support both clinical diagnostics and biomedical research, helping laboratories identify disease-associated genetic variants and enabling precision medicine approaches.

■ Product Technologies

Vicbio Biotechnology Co., Ltd. provides the full range of ViennaLab Diagnostics products.

⇨ Inquire or Order immediately ⇦

●RealFast™ Assays

RealFast™ assays are based on real-time fluorescence PCR technology, offering a rapid and user-friendly solution for detecting genetic variations.

These assays are designed to detect: Single nucleotide polymorphisms (SNPs) and Copy number variations (CNVs).RealFast™ assays enable laboratories to perform highly sensitive and specific molecular testing with fast turnaround times, making them suitable for both clinical diagnostics and research applications.

●StripAssays®

StripAssays® utilize reverse hybridization technology, enabling the simultaneous detection of multiple genetic variants in a single test.

Key features include:

☉Detection of up to 38 genetic variants in parallel

☉Multiplex mutation analysis

☉Reliable and reproducible detection performance

This technology is widely used for genetic disease screening, mutation analysis, and pharmacogenetic testing.

●Next-Generation Sequencing (NGS) Solutions

Next-generation sequencing (NGS) is transforming both medical diagnostics and biomedical research.ViennaLab Diagnostics offers integrated NGS workflows, covering the entire process from: Library preparation, Sequencing workflows, Proprietary bioinformatics analysis.These solutions provide laboratories with comprehensive genetic analysis capabilities, supporting applications in precision medicine, genetic research, and microbiome analysis.

■ Application Areas

●Cancer Therapy

Modern cancer treatment requires precise identification of cancer-associated genetic variants. ViennaLab Diagnostics provides high-sensitivity molecular testing technologies that support optimized cancer treatment strategies.For example, somatic pathogenic variants in genes such as BRAF, EGFR, KRAS, and NRAS play critical roles in determining therapeutic response. Identifying these variants enables patient stratification and targeted therapy selection.Additionally, genetic variants in drug metabolism genes, such as DPYD and TPMT, can significantly influence patient responses to chemotherapy. These variants are increasingly incorporated into clinical treatment guidelines, highlighting the importance of pharmacogenetic testing in oncology.

●Hereditary Diseases

ViennaLab Diagnostics test kits provide reliable diagnostic tools for hereditary disease detection.Hereditary disorders arise from genetic abnormalities, which may include:Variants in single genes, Alterations in multiple genes, Chromosomal gains or losses, Mitochondrial genetic defects. ViennaLab’s molecular technologies enable rapid and accurate diagnosis of both monogenic and polygenic diseases, supporting multiple inheritance patterns including:Single-gene inheritance, Multifactorial inheritance, Chromosomal abnormalities, Mitochondrial inheritance.

●Genetic Susceptibility

The presence of specific genetic variants or allele combinations may increase an individual’s susceptibility to certain diseases.ViennaLab Diagnostics provides reliable testing methods for genetic risk assessment, supporting:Early disease risk evaluation, Preventive healthcare strategies, Early diagnosis before disease onset.These capabilities contribute to the growing field of predictive and preventive medicine.

●Microbiome Analysis

ViennaLab Diagnostics also offers technologies for comprehensive microbiome analysis.The microbiome represents the complete collection of genetic material within microbial communities. Analysis of this genetic information enables researchers to characterize microbial populations and their functional roles. Studies have shown that the composition and diversity of the human gut microbiome are associated with a wide range of health and disease phenotypes, making microbiome analysis an important area of biomedical research.

●Pharmacogenomics

ViennaLab Diagnostics provides pharmacogenomic testing solutions to support personalized medicine.Genetic polymorphisms in drug metabolism pathways can significantly alter an individual’s response to medications. As knowledge of genetic variations in drug-metabolizing enzymes continues to expand, pharmacogenomic testing enables clinicians to optimize drug selection and dosage for individual patients.This approach helps improve treatment efficacy while reducing adverse drug reactions, contributing to the advancement of precision medicine.

■ Product List